Medicine
Volume 36, Issue 6 , Pages 315-320 , June 2008

Bronchiectasis

References 

  1. Barker AF. Bronchiectasis. N Engl J Med. 2002;346:1383–1393
  2. Wilson R, Boyton R. Bronchiectasis. In:  Laurent GJ,  Shapiro SD editor. Encyclopedia of respiratory medicine. Oxford, UK: Elsevier; 2006;
  3. Cohen M, Sahn SA. Bronchiectasis in systemic disease. Chest. 1999;116:1063–1074
  4. Patel IS, Vlahos I, Wilkinson TM, et al. Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;170:400–407
  5. Singleton R, Morris A, Redding G, et al. Bronchiectasis in Alaska native children: causes and clinical courses. Pediatr Pulmonol. 2000;29:182–187
  6. Callahan CW. Bronchiectasis: abated or aborted?. Respiration. 2005;72:225–226
  7. Twiss J, Metcalfe R, Edwards E, et al. New Zealand national incidence of bronchiectasis “too high” for a developed country. Arch Dis Child. 2005;90:737–740
  8. Chang AB, Grimwood K, Mulholland EK, et al. Bronchiectasis in indigenous children in remote Australian communities. Med J Aust. 2002;177:200–204
  9. Clark NS. Bronchiectasis in childhood. Br Med J. 1963;1:80–88
  10. Sayajakangas O, Keistinen T, Tuuponen T, et al. Evaluation of the incidence and age distribution of bronchiectasis from the Finnish Hospital Discharge Register. Cent Eur J Public Health. 1998;6:235–237
  11. Morrissey BM, Harper RW. Bronchiectasis: sex and gender considerations. Clin Chest Med. 2004;25:361–372
  12. Pasteur MC, Helliwell SM, Houghton SJ, et al. An investigation of causative factors in patients with bronchiectasis. Am J Respir Crit Care Med. 2000;162:1277–1284
  13. Boyton RJ, Altmann DM. Natural killer cells, killer immunoglobulin-like receptors and human leucocyte antigen class I in disease. Clin Exp Immunol. 2007;149:1–8
  14. Boyton RJ, Smith J, Ward R, et al. HLA-C and killer cell immunoglobulin-like receptor (KIR) genes in susceptibility to bronchiectasis. Am J Respir Crit Care Med. 2006;176:327–333
  15. Gadola SD, Mains-Teissererc HT, Trowsdale J, et al. TAP deficiency syndrome. Clin Exp Immunol. 2000;121:173–178
  16. Boyton RJ, Smith J, Jones M, et al. Human leucocyte antigen (HLA) class II association in idiopathic bronchiectasis, a disease of chronic lung infection, implicates a role for adaptive immunity. Clin Exp Immunol. 2008;[Epub ahead of print]
  17. Boyton R, Reynolds C, Wahid F, et al. IFNγ and CXCR-1 gene polymorphisms in idiopathic bronchiectasis. Tissue Antigens. 2006;68:325–330
  18. Hansell D. Bronchiectasis. Radiol Clin North Am. 1998;36:107–128
  19. Wickremasinghe M, Ozerovitch LJ, Davies G, et al. Non-tuberculosis mycobecteria in patients with bronchiectasis. Thorax. 2005;60:1045–1051
  20. Stevens DA, Schwartz HJ, Lee JY, et al. A randomized trial of itraconazole in allergic pulmonary aspergillosis. N Engl J Med. 2000;342:756–762
  21. Loebinger MR, Wilson R. Pharmacotherapy for bronchiectasis. Expert Opin Pharmacother. 2007;8:3183–3193
  22. Martínez-García MA, Soler-Cataluña JJ, Perpiñá-Tordera M, et al. Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis. Chest. 2007;132:1565–1572

PII: S1357-3039(08)00099-6

doi: 10.1016/j.mpmed.2008.03.006

Medicine
Volume 36, Issue 6 , Pages 315-320 , June 2008

Article Tools

* Image Usage & Resolution